+

WO2002000702A3 - Regulation de la serine protease specifique de l'epiderme humain - Google Patents

Regulation de la serine protease specifique de l'epiderme humain Download PDF

Info

Publication number
WO2002000702A3
WO2002000702A3 PCT/EP2001/007292 EP0107292W WO0200702A3 WO 2002000702 A3 WO2002000702 A3 WO 2002000702A3 EP 0107292 W EP0107292 W EP 0107292W WO 0200702 A3 WO0200702 A3 WO 0200702A3
Authority
WO
WIPO (PCT)
Prior art keywords
serine protease
human epidermis
regulation
specific serine
reagents
Prior art date
Application number
PCT/EP2001/007292
Other languages
English (en)
Other versions
WO2002000702A2 (fr
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Ag
Shyam Ramakrishnan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Shyam Ramakrishnan filed Critical Bayer Ag
Priority to AU2001269097A priority Critical patent/AU2001269097A1/en
Publication of WO2002000702A2 publication Critical patent/WO2002000702A2/fr
Publication of WO2002000702A3 publication Critical patent/WO2002000702A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des réactifs qui régulent l'activité de la sérine protéase spécifique de l'épiderme humain ainsi que des réactifs se liant à des produits géniques de la sérine protéase spécifique de l'épiderme humain qui peuvent être utilisés pour réguler la dégradation matricielle extracellulaire. Cette régulation est utilisée, en particulier, dans le traitement des métastases des cellules malignes, de l'angiogenèse tumorale, de l'inflammation, de l'athérosclérose, des maladies neurodégénératives et des infections pathogènes.
PCT/EP2001/007292 2000-06-26 2001-06-26 Regulation de la serine protease specifique de l'epiderme humain WO2002000702A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001269097A AU2001269097A1 (en) 2000-06-26 2001-06-26 Regulation of human epidermis-specific serine protease

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21425900P 2000-06-26 2000-06-26
US60/214,259 2000-06-26

Publications (2)

Publication Number Publication Date
WO2002000702A2 WO2002000702A2 (fr) 2002-01-03
WO2002000702A3 true WO2002000702A3 (fr) 2003-02-13

Family

ID=22798397

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007292 WO2002000702A2 (fr) 2000-06-26 2001-06-26 Regulation de la serine protease specifique de l'epiderme humain

Country Status (2)

Country Link
AU (1) AU2001269097A1 (fr)
WO (1) WO2002000702A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012788A2 (fr) * 1999-08-18 2001-02-22 Zymogenetics, Inc. Polypeptide ztryp1 de type tryptase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001012788A2 (fr) * 1999-08-18 2001-02-22 Zymogenetics, Inc. Polypeptide ztryp1 de type tryptase

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 28 February 2001 (2001-02-28), PRESNELL SR AND TAFT DW: "Tryptase-like polypeptide ztryp1", XP002215253, retrieved from E.B.I., HINXTON, U.K. Database accession no. AX082990 *
DATABASE EMBL [online] 28 February 2001 (2001-02-28), PRESNELL SR AND TAFT DW: "Tryptase-like polypeptide ztryp1", XP002215254, retrieved from E.B.I., HINXTON, U.K. Database accession no. AX082991 *
DATABASE EMBL [online] 3 August 1999 (1999-08-03), NCI-CGAP: "wd26a04.x1 Soares_NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:2329230 3' similar to SW:MCT7_MOUSE Q02844 MAST CELL PROTEASE 7 PRECURSOR mRNA sequence.", XP002215255, retrieved from E.B.I., HINXTON, U.K. Database accession no. AI935051 *
MIN HAE-KI ET AL: "Human mouse mast cell protease 7-like tryptase genes are pseudogenes.", JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, vol. 107, no. 2 Part 2, February 2001 (2001-02-01), pages 315 - 321, XP008008869, ISSN: 0091-6749 *
PALLAORO MICHELE ET AL: "Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 6, 5 February 1999 (1999-02-05), pages 3355 - 3362, XP002177260, ISSN: 0021-9258 *
VANDERSLICE P ET AL: "HUMAN MAST CELL TRYPTASE: MULTIPLE CDNAS AND GENES REVEAL A MULTIGENE SERINE PROTEASE FAMILY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 87, 1 May 1990 (1990-05-01), pages 3811 - 3815, XP002073694, ISSN: 0027-8424 *
WONG G W ET AL: "Identification of a new member of the tryptase family of mouse and human mast cell proteases which possesses a novel COOH-terminal hydrophobic extension", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 274, no. 43, 22 October 1999 (1999-10-22), pages 30784 - 30793, XP002177259, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
AU2001269097A1 (en) 2002-01-08
WO2002000702A2 (fr) 2002-01-03

Similar Documents

Publication Publication Date Title
WO2001096538A3 (fr) Regulation de la serine protease transmembranaire humaine
Murphy et al. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases
Sorsa et al. A trypsin‐like protease from Bacteroides gingivalis: partial purification and characterization
NO20025376D0 (no) Nye multicykliske forbindelser og anvendelser derav
PL351956A1 (en) Strain bacillus pumilus for control of plant diseases
PL352318A1 (en) Fish serine proteinases, and pharmaceutical and cosmetic use of same
WO2002000860A3 (fr) Nouvelles proteases
UA84025C2 (en) Normal;heading 1;heading 2;2-(QUINOXALIN-5-YLSULFONYLAMINO)-BENZAMIDE COMPOUNDS AS CCK2 MODULATORS
IL172506A0 (en) New biological entities and the use thereof
WO2002008392A3 (fr) Regulation de la serine protease humaine semblable a matriptase
AU2001259353A1 (en) Novel mutated form of arginine deiminase
WO2001096378A3 (fr) Regulation de la serine protease humaine de type epithin
AU2936599A (en) Novel matrix metalloproteinase inhibitors and down-regulators
WO2001098340A3 (fr) Regulation d'une enzyme du type protease mastocytaire humaine 6
WO2007048985A3 (fr) Substance pour restaurer une co-expression et une interaction normales entre les proteines lox et nrage
WO2002000702A3 (fr) Regulation de la serine protease specifique de l'epiderme humain
WO2001098466A3 (fr) Regulation de la serine protease semblable a la prostasine humaine
AU2826801A (en) Surface modified supporting materials for binding biological materials, method for the production and use thereof
WO2001079466A3 (fr) Regulation de la serine protease semblable a l'epithine humaine
AU2001284793A1 (en) Production and use of inducible enzymes from trichoderma and bacteria for control of plant pests and for industrial processes
WO2001098467A3 (fr) Regulation de la serine protease humaine de type prostasine
WO2001072973A3 (fr) Regulation d'une enzyme humaine de type heparanase
WO2001085959A3 (fr) Regulation de la protease de type lysostaphine humaine
WO2001062941A3 (fr) Regulation de l'enzyme 2 semblable a la gelatinase b humaine
WO2002012461A3 (fr) Regulation de la serine protease membranaire humaine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载